1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy

Technology appraisal guidance [TA520] Published: 16 May 2018

  • Guidance
  • Tools and resources
  • Information for the public
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 244 KB 16 May 2018  

Final appraisal determination

  • Final appraisal determination  
  • Final appraisal determination document PDF 352 KB 09 April 2018  
  • Committee papers PDF 4.05 MB 09 April 2018  
  • Public committee slides PDF 707 KB 09 April 2018  

Draft guidance: 2

  • Draft guidance: 2  
  • Appraisal consultation document PDF 379 KB 11 October 2017  
  • Committee papers PDF 4.08 MB 11 October 2017  
  • Public committee slides PDF 515 KB 11 October 2017  

Draft guidance

  • Draft guidance  
  • Appraisal consultation document PDF 563 KB 03 August 2017  
  • Committee papers PDF 35.34 MB 03 August 2017  
  • Public committee slides PDF 1.23 MB 03 August 2017  

Invitation to participate

  • Final scope PDF 239 KB 15 December 2016  
  • Final matrix PDF 297 KB 15 December 2016  
  • NICE's response to comments on the draft scope and provisional matrix PDF 315 KB 15 December 2016  
  • Equality impact assessment (Scoping) PDF 171 KB 15 December 2016